Although a broad scientific consensus supports the pathogenic role of the NLRP3 inflammasome in kidney diseases, its activation exhibits remarkable functional heterogeneity across disease stages, cell types (e.g., tubular epithelial cells, podocytes, macrophages, dendritic cells), and even patient subpopulations. This evidence concerns the gene NLRP3 and kidney disorder.